Development and validation of a stability-indicating assay including the isolation and characterization of degradation products of metaxalone by LC-MS.
Biomed Chromatogr
; 27(12): 1733-40, 2013 Dec.
Article
em En
| MEDLINE
| ID: mdl-23881540
A stability-indicating reverse-phase high-performance liquid chromatography-mass spectrometric method was developed and validated for the assay of metaxalone through forced degradation under acidic, alkaline, photo, oxidative and peroxide stress conditions. Separation of degradation products was accomplished on a reverse-phase Phenomenex C18 (250 × 4.6 mm, 5 µm) column thermostated at 25 °C using 10 mM aqueous ammonium acetate: methanol (35:65 v/v) as mobile phase in an isocratic mode of elution. The eluents were detected at 275 nm by photo diode array detector and mass detectors connected in series. Two unknown base hydrolysis products of metaxalone were identified and characterized as (a) methyl 3-(3,5-dimethylphenoxy)-2-hydroxypropylcarbamate and (b) 1-(3,5-dimethylphenoxy)-3-aminopropan-2-ol by MS, (1)H NMR and FTIR spectroscopy. The method was validated as per International Conference on Harmonization guidelines and metaxalone was selectively determined in presence of its degradation impurities, demonstrating its stability-indicating nature.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Espectrometria de Massas
/
Cromatografia Líquida
/
Oxazolidinonas
Tipo de estudo:
Prognostic_studies
Idioma:
En
Revista:
Biomed Chromatogr
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
Índia